Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML
Data up to Jan 2025
Total Citations Per Year
Abstract
References (10)
Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients
1993 • 434 citations
Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression
1992 • 202 citations
An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer
1992 • 87 citations
An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer
1992 • 80 citations
Therapy of Acute-Phase Chronic Myelogenous Leukemia with Intensive Chemotherapy, Blood Cell Autotransplantation and Cyclosporine A
1992 • 61 citations
Retrovirus-Mediated Gene Transfer as an Approach to Analyze Neuroblastoma Relapse after Autologous Bone Marrow Transplantation
1992 • 57 citations
Mobilization of Cytogenetically ‘Normal’ Blood Progenitors Cells by Intensive Conventional Chemotherapy for Chronic Myeloid and Acute Lymphoblastic Leukemia
1993 • 42 citations
Intensive combination chemotherapy and autologous bone marrow transplantation leads to the reappearance of philadelphia chromosome-negative cells in chronic myelogenous leukemia
1991 • 34 citations
Use of Cell-Free Retroviral Vector Preparations for Transduction of Cells from the Marrow of Chronic Phase and Blast Crisis Chronic Myelogenous Leukemia Patients and from Normal Individuals
1992 • 20 citations
Molecular Analysis of Retroviral Transduction in Chronic Myelogenous Leukemia
1991 • 9 citations
Cited By (0)
No citing papers found in database